[1]
J. Rico-Fontalvo, “SGLT2 Inhibitors and nephroprotection in diabetic kidney disease: From mechanisms of action to the latest evidence in the literature”, J Clini Nephrol, vol. 4, no. 2, pp. 044–055, Aug. 2020.